OKLAHOMA CITY, March 24, 2026 /PRNewswire/ -- Biozen, LLC, today announced it will present prospective clinical validation data for its cuffless blood pressure technology at the American College of ...

A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test’s consistent clinical performance across nodule sizes and patient populations LOUISVILLE, Colo., March 20, 2026 ...

For shareholders of Anixa Biosciences, the current investment thesis hinges on a single, critical transition: moving promising research from the laboratory into confirmed clinical efficacy. The ...

Hello, and thank you for standing by. At this time, I would like to welcome everyone to the CareDx Investor Webinar Call. [Operator Instructions] I would now like to turn the conference over to ...

Ultra‑Sensitive, Non‑Invasive Surveillance Solution Expected to Launch Commercially in the U.S. in 2027 as Part of CareDx’s Transplant+ Precision Medicine Portfolio CareDx, Inc. (Nasdaq: CDNA) — The ...

Dr. Mazzone and colleagues report on a cell-free DNA fragmentome assay (DELFIscore) for the classification of lung cancer (1). We have concerns and recommendations. Study participants were enrolled ...

Musculoskeletal disorders remain one of the leading causes of pain, disability, and socioeconomic burden worldwide. Across orthopedics, sports medicine, and rehabilitation, a deeper understanding of ...

n = 345 adults seeking web based ADHD assessment (predominantly female; mean age = 35). Sensitivity = 80.6% and Positive Predictive Value = 94.9%. False positive rate = 12% versus 56% for the clinical ...

For any document version listed below, click on its file name to view it. The current [ ] version of the document is downloaded by default when the document is referenced elsewhere on the site.

Health care leaders may want to keep a closer eye on clinical validation for artificial intelligence (AI)-enabled medical devices (AIMDs), based on a recent JAMA Health Forum study. The study examined ...

Artificial intelligence-enabled medical devices with no clinical validation were more likely to be the subject of recalls, according to a study published in JAMA Health Forum. The study, published on ...